CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-18 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,127 | $0.10 | $13K | 1,601,546 |
| 2018-12-18 | Milligan John C.K. IV President/Secretary | Sale | −129,127 | $3.64 | $470K | 1,472,419 |
| 2018-12-18 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,127 | 0 | ||
| 2018-12-17 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-12-17 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $3.75 | $484K | 1,472,419 |
| 2018-12-17 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 129,127 | ||
| 2018-12-13 | Bernick Brian Director | Exercise or conversion | +91,910 | $0.10 | $9K | 6,649,281 |
| 2018-12-13 | Bernick Brian Director | Sale | −91,910 | $4.12 | $379K | 6,557,371 |
| 2018-12-13 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,910 | 0 | ||
| 2018-12-12 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-12-12 | Bernick Brian Director | Sale | −91,400 | $4.18 | $382K | 6,557,371 |
| 2018-12-12 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 91,910 | ||
| 2018-12-07 | Bernick Brian Director | Gift | −190,000 | 52,000 | ||
| 2018-12-07 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,458,559 |
| 2018-12-07 | Finizio Robert G CEO | Sale | −92,000 | $4.60 | $424K | 18,366,559 |
| 2018-12-07 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 184,910 | ||
| 2018-12-06 | Finizio Robert G CEO | Gift | −27,000 | 18,366,559 | ||
| 2018-12-06 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,458,559 |
| 2018-12-06 | Finizio Robert G CEO | Sale | −92,000 | $4.57 | $421K | 18,366,559 |
| 2018-12-06 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 276,910 |
Page 16 of 24 · 463 trades